Where’s Our Share?
A healthy economy may be one pretext for renewed fundraising appeals—but then again, so could an unpredictable new tax regime.
A healthy economy may be one pretext for renewed fundraising appeals—but then again, so could an unpredictable new tax regime.
This month: training for directors, IP for non-writers, the state of queer theatre, diversiyfing theatre training, and West African stages.
Directors set the table for our theatrical meals, and preparation is key.
We know too well the laments about shrinking critical jobs and authority. But are we looking for the future in all the wrong places?
The challenge for artists: to keep our attention on human stories and larger questions, not on our distractor-in-chief.
For this year’s preview of U.S. theatre’s offerings, we look at the how and why as much as the what.
Our magazine doesn’t include the Bard on its annual most-produced lists, but this year he snuck his way to the top anyway.
For all its heightened relevance and accountability, documentary theatre can’t be constrained by its subject.
You can tell where theatre happens from its name.
If you can gauge a nation’s health by its theatre, China looks vital, youthful—and ambivalent.